首页 | 本学科首页   官方微博 | 高级检索  
检索        

Graves眼病3种药物治疗方案的成本-效果分析
引用本文:奚月芬,高芸.Graves眼病3种药物治疗方案的成本-效果分析[J].中国药房,2006,17(1):34-35.
作者姓名:奚月芬  高芸
作者单位:江苏省原子医学研究所附属江原医院,无锡市,214063
摘    要:目的研究Graves眼病(GO)3种药物治疗方案的成本-效果。方法94例GO患者分为3组,分别给予甲基强的松龙(A组)、地塞米松(B组)和强的松(C组),用成本-效果分析法进行评价。结果A、B、C组成本分别为2956.76元、2059.42元、31.09元;总有效率分别为93.94%、93.75%、51.72%;成本-效果比分别为31.47元、21.97元、0.60元;A、B组相对于C组的增量成本-效果比分别为69.30元、48.26元。结论从药物经济学角度分析,B方案治疗GO相对较好。

关 键 词:Graves眼病  治疗方案  成本-效果分析
文章编号:1001-0408(2006)01-0034-02
收稿时间:09 22 2005 12:00AM
修稿时间:11 30 2005 12:00AM

3 Therapeutical Schemes on Graves Ophthalmopathy: Cost-effectiveness Analysis
XI Yuefen,GAO Yun.3 Therapeutical Schemes on Graves Ophthalmopathy: Cost-effectiveness Analysis[J].China Pharmacy,2006,17(1):34-35.
Authors:XI Yuefen  GAO Yun
Institution:The Affiliated Jiangyuan Hospital, Institute of Nuclear Medicinein in Jiangsu Province,Wuxi 214063, China
Abstract:OBJECTIVE:To Study the cost-effectiveness among3therapeutical schemes in the treatment of Graves ophthalmopathy.METHODS:A total of94cases with Graves ophthalmopathy were randomized into3groups,Group A was assigned to receive medrat,Group B to receive dexamethasone and Group C to receive prednisone,the outcomes were evaluated in terms of the cost-effectiveness analysis.RESULTS:The costs for Group A,B and C were2956.76yuan,2059.42yuan and31.09yuan,respectively.The total effective rates were93.94%,93.75%and51.72%,respectively.The cost-effec-tiveness ratios were31.47yuan,21.97yuan and0.60yuan,respectively.The incremental cost-effectiveness ratios of Group A and B were69.30yuan and48.26yuan,respectively as against Group C.CONCLUSION:In terms of pharmacoeconomics,Group B is comparatively the best option in treating Graves ophthalmopathy.
Keywords:Graves ophthalmopathy  Therapeutical schemes  Cost-effectiveness analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号